Kevin C. Oeffinger, MD, Chair - ACS Guideline Development Group

Kevin Oeffinger, MD, is a family physician, a member of the Duke Cancer Institute (DCI), the founding Director of the DCI Center for Onco-Primary Care, and Director of the DCI Supportive Care and Survivorship Center. Prior to joining Duke in April 2017, Dr. Oeffinger was the Director of the Cancer Survivorship Center at Memorial Sloan Kettering Cancer Center. He has a long-standing track record of NIH-supported research in cancer screening and survivorship and has served in a leadership capacity in various cancer-focused and primary care-focused national committees and organizations, including the American Society of Clinical Oncology, the American Cancer Society, and the American Academy of Family Physicians.

Elizabeth T.H. Fontham, DrPH, MPH, Co-chair, ACS Guideline Development Group

Dr. Elizabeth (Terry) Fontham is Founding Dean of Louisiana State University Health Sciences Center School of Public Health (LSUHSC SPH) and Professor of Epidemiology. She also holds a joint appointment in the LSUHSC School of Medicine Department of Pathology. Dr. Fontham’s area of expertise is cancer epidemiology, with interest in tobacco and nutrition-related cancers and gastric cancer premalignant lesions. She has authored more than 170 publications in peer-reviewed scientific journals, book chapters, and monographs. Her current research includes innovative approaches to cervical cancer screening and long-term health effects related to exposures as a result of the Gulf of Mexico Oil Spill.

Timothy R. Church, PhD

Dr. Timothy R. Church is a tenured professor at the University of Minnesota School of Public Health. His research interests is in chronic disease screening and prevention, and work including the Minnesota Colon Cancer Control Study, the Prostate Lung Colon and Ovarian Cancer Screening Trial, the National Colonoscopy Screening Trial, the Lung Screening Study, the National Lung Screening Trial, the Minnesota-Wisconsin Men’s Health Study, and the Colon Cancer Family Registry, as well as numerous studies on HIV/AIDS, cardiac arrhythmias, and occupational violence and injury. He has over 130 research publications and sits on national and international advisory boards, including the National Lung Screening Trial Executive Committee, and the PROSPR Consulting Committee.

Ruth Etzioni, PhD

Dr. Ruth Etzioni’s work focuses on statistical and computer modeling for policy development. A critical component of this work is the estimation of disease natural history and progression which then forms a substrate for modeling comparative- and cost-effectiveness of alternative interventions. Dr. Etzioni’s models of disease have been used to estimate the lifetime probabilities of prostate cancer and its outcomes, the extent of associated overdiagnosis, and quantify the roles of screening and changes in receipt of initial therapies in mortality declines. She serves on three national panels on prostate cancer early detection. Her work on prostate cancer modeling is done as part of the National Cancer Institute’s Cancer Intervention and Surveillance Modeling Network (CISNET) consortium, for which she serves on the steering committee and is the Principal Investigator on the Prostate Cancer Coordinating Center.

Carmen E. Guerra, MD

Dr. Carmen Guerra is an Associate Professor of Medicine at the Perelman School of Medicine, the University of Pennsylvania. Dr. Guerra is the Associate Chief of Staff and Associate Director of Diversity and Outreach of the Abramson Cancer Center, where she founded and currently co-directs two programs focused on the vulnerable populations of Philadelphia: University of Pennsylvania Health System Colorectal Cancer Screening Navigation Program and the Health Woman Program- Penn Breast Health Initiative, programs which increase access to cancer screening to minority populations. She is the recipient of several NIH and ACS grants that have supported her research to better understand and overcome barriers to cancer screening. She is also the recipient of the Amos Medical Faculty Development Program fellowship from the Robert Wood Johnson Foundation. Dr. Guerra co-chairs the Mission Outcomes committee for the ACS, currently serves as a member and Board Scientific Officer of the ACS Board of Directors, and is a member of the Northeast Region Division of the ACS.

Ya-Chen Tina Shih, PhD

Dr. Shih is Professor and Chief of Section of Cancer Economics and Policy at the Department of Health Services Research, University of Texas MD Anderson Cancer Center. Dr. Shih’s area of expertise is in health economics and health services research and with particular interest in the economics of cancer. She has over 110 peer-reviewed publications and has co-authored 4 book chapters. Her current research includes the impact of technology diffusion in costs and outcomes of cancer, evaluating the cost-effectiveness of various policy, behavioral, and medical interventions for cancer, and methodological issues in health services research.

Louise C. Walter, MD

Dr. Louise Walter is a Professor of Medicine and Interim Chief of the Division of Geriatrics at the University of California, San Francisco (UCSF). She is a geriatrician at the San Francisco VA and Director of their Health Services Research Enhancement Award Program. Dr. Walter’s research interests include prognostication and cancer screening in older persons with particular interest in studying the importance of life expectancy, rather than age, in determining real-world risks and benefits of cancer screening in older adults. Dr. Walter has more than 50 peer-reviewed publications and has co-authored several book chapters. Her current work focuses on downstream outcomes of prostate-specific antigen screening in older men and the juxtaposition of lag-time-to-benefit of preventive services and life expectancy to help individualize screening decisions.

Andrew Wolf, MD

Dr. Andrew Wolf is a General Internist physician and Associate Professor of Medicine at the University of Virginia (UVA) School of Medicine in Charlottesville, Virginia. He serves as Associate Program Director for the UVA Internal Medicine Residency Program and directs its Primary Care Track. His areas of expertise are cancer screening and medical education, with research interest in enhancing patient involvement in cancer screening decisions. For his educational accomplishments, he has won 16 teaching awards and has achieved the “Best Doctors in America” distinction for four of the past eight years. Dr. Wolf has been involved with guideline development with the ACS since 2001, and chaired the ACS Prostate Cancer Advisory Committee that developed the 2010 prostate cancer screening guideline.